These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26153241)

  • 41. Effect of Ivabradine on Endothelial Function in Patients with Stable Angina Pectoris: Assessment with the Endo-PAT 2000 Device.
    Jedlickova L; Merkovska L; Jackova L; Janicko M; Fedacko J; Novakova B; Chmelarova A; Majernik J; Pella D
    Adv Ther; 2015 Oct; 32(10):962-70. PubMed ID: 26525390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rate control with ivabradine: angina pectoris and beyond.
    Parakh N; Bhargava B
    Am J Cardiovasc Drugs; 2011; 11(1):1-12. PubMed ID: 21090826
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials.
    Fox K; Komajda M; Ford I; Robertson M; Böhm M; Borer JS; Steg PG; Tavazzi L; Tendera M; Ferrari R; Swedberg K
    Eur Heart J; 2013 Aug; 34(29):2263-70. PubMed ID: 23536611
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomised, double-blind, placebo-controlled trial of ivabradine in patients with acute coronary syndrome: effects of the If current inhibitor ivabradine on reduction of inflammation markers in patients with acute coronary syndrome--RIVIERA trial study design and rationale.
    Dominguez-Rodriguez A; Fard SS; Abreu-Gonzalez P; Bosa-Ojeda F; Consuegra-Sanchez L; Jiménez-Sosa A; Grande AS; Kaski JC
    Cardiovasc Drugs Ther; 2009 Jun; 23(3):243-7. PubMed ID: 19229603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Atrial Fibrillation After Coronary Artery Bypass Surgery: Can Ivabradine Reduce Its Occurrence?
    Abdel-Salam Z; Nammas W
    J Cardiovasc Electrophysiol; 2016 Jun; 27(6):670-6. PubMed ID: 27006322
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coronary artery disease: Stable CAD does not SIGNIFY ivabradine therapy.
    Lim GB
    Nat Rev Cardiol; 2014 Nov; 11(11):621. PubMed ID: 25223448
    [No Abstract]   [Full Text] [Related]  

  • 47. Ivabradine in Patients with Stable Coronary Artery Disease: A Rationale for Use in Addition to and Beyond Percutaneous Coronary Intervention.
    Godino C; Colombo A; Margonato A
    Clin Drug Investig; 2017 Feb; 37(2):105-120. PubMed ID: 27766510
    [TBL] [Abstract][Full Text] [Related]  

  • 48. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
    Abdel-Salam Z; Rayan M; Saleh A; Abdel-Barr MG; Hussain M; Nammas W
    Cardiol J; 2015; 22(2):227-32. PubMed ID: 25179314
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of the Funny Current Inhibitor Ivabradine in Cardiac Pharmacotherapy: A Systematic Review.
    Petite SE; Bishop BM; Mauro VF
    Am J Ther; 2018; 25(2):e247-e266. PubMed ID: 26910057
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravenous ivabradine for control of heart rate during coronary CT angiography: A randomized, double-blind, placebo-controlled trial.
    Cademartiri F; Garot J; Tendera M; Zamorano JL
    J Cardiovasc Comput Tomogr; 2015; 9(4):286-94. PubMed ID: 26088378
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of ivabradine-induced heart rate reduction on flow-mediated dilation measured with high-sensitivity ultrasound in patients with stable coronary heart disease.
    Jochmann N; Schröter F; Knebel F; Hättasch R; Gericke C; Stangl K; Baumann G; Stangl V
    Cardiovasc Ultrasound; 2014 Jan; 12():5. PubMed ID: 24479706
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Arrhythmic effects of ivabradine in patients with coronary artery disease.
    Murat SN; Orcan S; Akdemir R; Dogan M; Kara E; Balci M
    Clin Invest Med; 2009 Oct; 32(5):E322-6. PubMed ID: 19796572
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT.
    Voors AA; van Veldhuisen DJ; Robertson M; Ford I; Borer JS; Böhm M; Komajda M; Swedberg K; Tavazzi L;
    Eur J Heart Fail; 2014 Apr; 16(4):426-34. PubMed ID: 24504937
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of ivabradine therapy on heart failure biomarkers.
    Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
    Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ivabradine, coronary artery disease, and heart failure: beyond rhythm control.
    Scicchitano P; Cortese F; Ricci G; Carbonara S; Moncelli M; Iacoviello M; Cecere A; Gesualdo M; Zito A; Caldarola P; Scrutinio D; Lagioia R; Riccioni G; Ciccone MM
    Drug Des Devel Ther; 2014; 8():689-700. PubMed ID: 24940047
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ivabradine reduced ventricular rate in patients with non-paroxysmal atrial fibrillation.
    Wongcharoen W; Ruttanaphol A; Gunaparn S; Phrommintikul A
    Int J Cardiol; 2016 Dec; 224():252-255. PubMed ID: 27661415
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.
    DiFrancesco D; Camm JA
    Drugs; 2004; 64(16):1757-65. PubMed ID: 15301560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of ivabradine on left ventricular remodelling after reperfused myocardial infarction: A pilot study.
    Gerbaud E; Montaudon M; Chasseriaud W; Gilbert S; Cochet H; Pucheu Y; Horovitz A; Bonnet J; Douard H; Coste P
    Arch Cardiovasc Dis; 2014 Jan; 107(1):33-41. PubMed ID: 24440004
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [New pharmacological approaches to ischemic heart disease].
    Raddino R; Della Pina P; Gorga E; Brambilla G; Regazzoni V; Gavazzoni M; Dei Cas L
    G Ital Cardiol (Rome); 2012 Oct; 13(10 Suppl 2):50S-54S. PubMed ID: 23096376
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heart rate modulation in stable coronary artery disease without clinical heart failure: What we have already learned from SIGNIFY?
    Perna GP; Vagnarelli F; Volterrani M; Battistoni I; Rapezzi C
    Contemp Clin Trials Commun; 2016 Dec; 4():58-63. PubMed ID: 29736470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.